17 Nov 2026, 08:24
Company Update—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 17 Nov 2026, 08:24 | AVITA Medical Reports Complete Cohealyx I Data | Company Update | — | 11001 | |
| 16 Nov 2026, 08:13 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 16 Nov 2026, 08:13 | Cleansing Notice | Securities Administration | — | 06018 | |
| 9 Nov 2026, 08:20 | AVITA Medical Investor Presentation November 2026 | Presentations | — | 03026 | |
| 9 Nov 2026, 08:20 | AVITA Medical to Host Investor Webinar Briefing | Presentations | — | 14014 | |
| 6 Nov 2026, 11:56 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 6 Nov 2026, 08:26 | AVITA 10Q Quarterly Reports for Q3 2026 | Periodic Reports | MS | 03014 | |
| 6 Nov 2026, 08:26 | AVITA Q3 Financial Results Earning Presentation | Presentations | MS | 03026 | |
| 6 Nov 2026, 08:26 | AVITA Medical Announces Q3 2026 Financial Results | Presentations | MS | 03014, 14014 | |
| 6 Nov 2026, 08:21 | AVITA announce CMS Finalized Valuations and Codes for RECELL | Company Update | — | 11001 | |
| 5 Nov 2026, 09:57 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 3 Nov 2026, 08:32 | Cleansing Notice | Securities Administration | — | 06018 | |
| 3 Nov 2026, 08:31 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 21 Oct 2026, 08:23 | AVITA to announce Q3 financial results November 6 AEDT | Periodic Reports | — | 03027 | |
| 7 Oct 2026, 10:26 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 6 Oct 2026, 10:12 | Change of Director's Interest Notice - MT | Director Interests | — | 02009 | |
| 6 Oct 2026, 09:28 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 6 Oct 2026, 09:00 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 15 Sept 2026, 09:49 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 11 Sept 2026, 12:04 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 10 Sept 2026, 09:19 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 10 Sept 2026, 09:15 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 9 Sept 2026, 11:20 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 7 Sept 2026, 15:37 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 3 Sept 2026, 08:19 | AVITA to participate in US bank investor conferences | Presentations | — | 12008, 14014 | |
| 19 Aug 2026, 08:04 | AVITA Investor Webinar Slides on PermeaDerm | Presentations | — | 03026 | |
| 19 Aug 2026, 08:01 | AVITA announces positive PermeaDerm study results | Company Update | MS | 11001, 14014 | |
| 12 Aug 2026, 11:22 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 10 Aug 2026, 09:50 | AVITA Medical Investor Presentation August 2026 | Presentations | — | 03026 | |
| 10 Aug 2026, 08:32 | AVITA Medical to Host Investor Webinar Briefing | Presentations | — | 14014 | |
| 10 Aug 2026, 08:24 | AVITA to participate at Canaccord Genuity Growth Conference | Company Administration | — | 12008 | |
| 7 Aug 2026, 11:41 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 7 Aug 2026, 08:26 | AVITA 10-Q Quarterly Report for Q2 2026 | Periodic Reports | MS | 03014 | |
| 7 Aug 2026, 08:26 | Half Yearly Report | Financial Results | MS | 03004 | |
| 7 Aug 2026, 08:26 | AVITA Q2 financial results earnings presentation | Presentations | MS | 03026 | |
| 7 Aug 2026, 08:26 | AVITA Medical announces Q2 2026 financial results | Quarterly Reports | MS | 03014, 19002, 19007 | |
| 6 Aug 2026, 09:48 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 15 July 2026, 08:24 | AVITA to Announce Second Quarter 2026 Financial Results | Presentations | — | 03027, 14014 | |
| 14 July 2026, 14:29 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 13 July 2026, 08:24 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 13 July 2026, 08:24 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 8 July 2026, 16:36 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 3 July 2026, 10:14 | Notification of cessation of securities - AVH | Securities Administration | — | 06027 | |
| 19 June 2026, 08:17 | AVITA Highlights first UK Clinical Experience with RECELL GO | Company Update | — | 11001 | |
| 11 June 2026, 10:26 | Financial Report on Form 8-K Dated 5 June 2026 | Periodic Reports | — | 03014, 06009 | |
| 11 June 2026, 10:24 | Change of Director's Interest Notice -SC JCC RM JSR MT CV JW | Director Interests | — | 02009 | |
| 11 June 2026, 10:23 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 11 June 2026, 10:04 | Notification regarding unquoted securities - AVH | Securities Administration | — | 06021 | |
| 4 June 2026, 10:28 | Statement of CDIs on issue - AVH | Securities Administration | — | 06007 | |
| 4 June 2026, 09:48 | 2026 ASM Board Chair Script | Letters & Addresses | — | 15002 |